The PharmaNutra Group will be present in Greece and Cyprus with its Cetilar® products, while SiderAL® Forte will be distributed […]
The American administrative body for patents, USPTO, communicates registration of the figurative and word marks of the two flagship PharmaNutra […]
PharmaNutra S.p.A. communicates that the Board of Directors has examined and approved the consolidated financial report as at 30th September 2020, […]
PharmaNutra launches a new TV, radio and digital campaign dedicated to the nutrition supplement ApportAL®. ApportAL®, the innovative nutritional supplement […]
Innovative, versatile and easy to apply – available in pharmacies from today – it’s an expansion to the patented Cetylated […]